Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension

American Heart Journal
D LevyM Levenstein

Abstract

The Hypertension and Lipid Trial (HALT) was undertaken to assess the efficacy and safety of doxazosin, a selective alpha 1- adrenergic blocker, in patients with hypertension in a clinical practice setting. The effects of doxazosin on office blood pressure, changes in lipid profiles, and theoretic coronary disease risk were studied. In an open, noncomparative, multicenter trial, 851 patients were studied for a maximum of 16 weeks. Doxazosin significantly reduced mean sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) by 15.2/12.5 mm Hg and standing SBP and DBP by 16.1/12.7 mm Hg in the total study population (n = 807; p = 0.0001), with no significant effect on heart rate. Mean total cholesterol levels were significantly reduced by 2.7%, low-density lipoprotein cholesterol levels by 2.4%, and mean triglyceride levels by 3.4% (all p values < 0.05). High-density lipoprotein (HDL) cholesterol levels were essentially unchanged. The mean ratio of total to HDL cholesterol was significantly reduced (p < 0.05). Mean predicted 5-year coronary disease risk was significantly reduced with doxazosin therapy by 14.7% in previously untreated patients (p < 0.0001) and by 1.7% in patients who were previously receiving antihy...Continue Reading

References

Jan 1, 1991·Circulation·K M AndersonW B Kannel
Feb 14, 1986·The American Journal of Medicine·M H Weinberger
Nov 19, 1987·The New England Journal of Medicine·W C WillettC H Hennekens
Nov 28, 1986·JAMA : the Journal of the American Medical Association·W P CastelliW B Kannel

❮ Previous
Next ❯

Citations

Feb 20, 2007·Postgraduate Medical Journal·Stephen S Connolly, John M Fitzpatrick
Feb 13, 1999·Journal of Clinical Pharmacology·W H Frishman, F Kotob
Jun 5, 2002·Congestive Heart Failure·Domenic A Sica
Jan 11, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
May 2, 2001·Current Medical Research and Opinion·D P MikhailidisR J Morgan
Mar 9, 2006·The Journal of Clinical Hypertension·Samuel J Mann
Jun 2, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yuko OhtaMichio Ueno
Jun 24, 2015·Current Opinion in Lipidology·Tarza J SiahmansurHandrean Soran
Apr 29, 2006·American Heart Journal·J Conor O'Shea, Robert M Califf
Apr 12, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·John A PapadakisEmmanuel S Ganotakis
May 26, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·S M Marshall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.